- Home
- GNLX vs GBLI Comparison
GNLX vs GBLI Comparison
Compare GNLX & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- GBLI
- Stock Information
- Founded
- GNLX 2001
- GBLI 2016
- Country
- GNLX United States
- GBLI United States
- Employees
- GNLX N/A
- GBLI N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- GBLI Property-Casualty Insurers
- Sector
- GNLX Health Care
- GBLI Finance
- Exchange
- GNLX Nasdaq
- GBLI Nasdaq
- Market Cap
- GNLX 103.6M
- GBLI 498.5M
- IPO Year
- GNLX 2023
- GBLI 2003
- Fundamental
- Price
- GNLX $2.27
- GBLI $35.82
- Analyst Decision
- GNLX Strong Buy
- GBLI
- Analyst Count
- GNLX 4
- GBLI 0
- Target Price
- GNLX $18.25
- GBLI N/A
- AVG Volume (30 Days)
- GNLX 141.5K
- GBLI 6.5K
- Earning Date
- GNLX 11-14-2024
- GBLI 11-07-2024
- Dividend Yield
- GNLX N/A
- GBLI 3.91%
- EPS Growth
- GNLX N/A
- GBLI 90.04
- EPS
- GNLX N/A
- GBLI 2.92
- Revenue
- GNLX $8,000.00
- GBLI $442,500,000.00
- Revenue This Year
- GNLX N/A
- GBLI N/A
- Revenue Next Year
- GNLX N/A
- GBLI $8.39
- P/E Ratio
- GNLX N/A
- GBLI $12.28
- Revenue Growth
- GNLX N/A
- GBLI N/A
- 52 Week Low
- GNLX $1.60
- GBLI $27.47
- 52 Week High
- GNLX $16.60
- GBLI $37.00
- Technical
- Relative Strength Index (RSI)
- GNLX 38.68
- GBLI 52.93
- Support Level
- GNLX $2.13
- GBLI $33.81
- Resistance Level
- GNLX $2.80
- GBLI $36.38
- Average True Range (ATR)
- GNLX 0.20
- GBLI 0.70
- MACD
- GNLX -0.04
- GBLI -0.11
- Stochastic Oscillator
- GNLX 14.21
- GBLI 67.22
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. The company's three primary segments are Commercial Specialty, Reinsurance operations, and Exited Lines. The majority of its revenue is from the Commercial Specialty segment. Geographically, the majority is from California.